Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192].

Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM

Open source

DOI: 10.1016/j.jconrel.2022.06.040
Published: 2022 Sep
Container: Journal of controlled release : official journal of the Controlled Release Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2022.06.040,
  title = {Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192].},
  author = {Fusser M and Øverbye A and Pandya AD and Mørch Ý and Borgos SE and Kildal W and Snipstad S and Sulheim E and Fleten KG and Askautrud HA and Engebraaten O and Flatmark K and Iversen TG and Sandvig K and Skotland T and Mælandsmo GM},
  year = {2022},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  doi = {10.1016/j.jconrel.2022.06.040},
  url = {https://doi.org/10.1016/j.jconrel.2022.06.040}
}

RIS

TY  - JOUR
TI  - Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192].
AU  - Fusser M
AU  - Øverbye A
AU  - Pandya AD
AU  - Mørch Ý
AU  - Borgos SE
AU  - Kildal W
AU  - Snipstad S
AU  - Sulheim E
AU  - Fleten KG
AU  - Askautrud HA
AU  - Engebraaten O
AU  - Flatmark K
AU  - Iversen TG
AU  - Sandvig K
AU  - Skotland T
AU  - Mælandsmo GM
PY  - 2022
JO  - Journal of controlled release : official journal of the Controlled Release Society
DO  - 10.1016/j.jconrel.2022.06.040
UR  - https://doi.org/10.1016/j.jconrel.2022.06.040
ER  -

APA

M, F., A, Ø., AD, P., Ý, M., SE, B., W, K., S, S., E, S., KG, F., HA, A., O, E., K, F., TG, I., K, S., T, S., & GM, M. (2022). Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192].. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2022.06.040

Source records

pubmed · retrieved 2026-09-25T00:14:33.830Z